Recent Updates
Recently added Catalysts
CTMX Positive Sentiment

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

Thursday, October 30, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: CytomX Therapeutics, Inc. has announced it will report its third quarter financial results on November 6, 2025, after the U.S. markets close. Following this announcement, the company will host a conference call and webcast to discuss the financials. The event marks a significant update for stakeholders interested in the company's financial performance and future outlook.
Price reaction · baseline $3.26 (2025-10-29 close) · hit after-hours · 1 other CTMX headline(s) in the window, move may be shared
day 0 close · peak
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is scheduled to report Q3 financial results, indicating ongoing business activity.
  • The company is engaging with investors through a conference call, showing transparency.
  • The use of masked, conditionally activated biologics highlights innovative approaches in their research.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+53%
120-day peak, hindsight
Typical move
6.8%
average across 7 past catalysts
Cash runway
~54 mo
Minimal dilution risk
Lead asset
CX-2009
Phase 2 · Neoplasms

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report third quarter financial results on Thursday, November 6, 2025, after the close of U.S. markets. Following the announcement, the Company will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT.
Participants may access the live webcast of the conference call from the Events and Presentations page of CytomX’s website at https://ir.cytomx.com/events-and-presentations. Participants may register for the conference call here and are advised to do so at least 10 minutes prior to joining the call. An archived replay of the webcast will be available on the Company’s website.
About CytomX Therapeutics, Inc.
SVP, Chief Financial Officer
Precision AQ (formerly Stern Investor Relations)

Frequently Asked Questions

When will CytomX report its Q3 financial results?

CytomX will report its Q3 financial results on November 6, 2025.

What time is the CytomX conference call?

The conference call will begin at 5:00 p.m. ET / 2:00 p.m. PT.

Where can I access the CytomX conference call webcast?

The webcast can be accessed from the Events and Presentations page on CytomX’s website.

How can I register for the conference call?

Participants can register for the call and should do so at least 10 minutes early.

Will there be a replay of the conference call?

Yes, an archived replay of the webcast will be available on CytomX’s website.

ShareAdd on Google
Tags: CTMX Viatris Investor Conferences Healthcare CytomX Therapeutics financial results Q3 2025 biologics
Last updated: Oct 30, 2025

Biotech snapshot

Cash runway
$330M liquidity · $6M/mo burn
~54 mo
Minimal dilution risk
Lead asset
CX-2009Phase 2
Neoplasms →

Catalyst track record

+53%
best trade around CTMX's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for CTMX.

See every catalyst's timing & PoA →